CDER Drug Safety Website Model Includes Elidel; Novartis Objects
Novartis objects to the inclusion of its eczema therapy Elidel in FDA's drug safety website model
Novartis objects to the inclusion of its eczema therapy Elidel in FDA's drug safety website model